Risk alleles in CFH and ARMS2 and the long-term natural history of age-related macular degenerationl: The beaver dam eye study

JAMA Ophthalmology

Volumn 131, Issue 3, 2013, Pages 383-392

  Klein, Ronald ^a   Myers, Chelsea E ^a   Meuer, Stacy M ^a   Gangnon, Ronald E ^a   Sivakumaran, Theru A ^b,c,d   Iyengar, Sudha K ^b,c   Lee, Kristine E ^a   Klein, Barbara E K ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE RELATED MACULOPATHY SUSCEPTIBILITY 2 PROTEIN; BIOLOGICAL MARKER; COMPLEMENT FACTOR H; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; COHORT ANALYSIS; DISEASE COURSE; EYE FUNDUS; FOLLOW UP; GENETIC ANALYSIS; GENETIC RISK; GENOTYPE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; COMPLEMENT FACTOR H; DISEASE PROGRESSION; FEMALE; HUMANS; INCIDENCE; MACULAR DEGENERATION; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS; RISK ASSESSMENT; RISK FACTORS; WISCONSIN;

EID: 84875164367     PISSN: 21686165     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaophthalmol.2013.713     Document Type: Article

References (71)

1. Seddon JM, Reynolds R, Maller J, Fagerness JA, Daly MJ, Rosner B. Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables. Invest Ophthalmol Vis Sci. 2009;50(5):2044-2053.
2. Yu Y, Reynolds R, Rosner B, Daly MJ, Seddon JM. Prospective assessment of genetic effects on progression to different stages of age-related macular degeneration using multistate Markov models. Invest Ophthalmol Vis Sci. 2012;53 (3):1548-1556.
3. Edwards AO, Ritter R III, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism and age-related macular degeneration. Science. 2005; 308(5720):421-424.
4. Haines JL, Hauser MA, Schmidt S, et al. Complement factor H variant increases the risk of age-related macular degeneration. Science. 2005;308(5720):419-421.
5. Klein RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphism in agerelated macular degeneration. Science. 2005;308(5720):385-389.
6. Fagerness JA, Maller JB, Neale BM, Reynolds RC, Daly MJ, Seddon JM. Variation near complement factor I is associated with risk of advanced AMD. Eur J Hum Genet. 2009;17(1):100-104.
7. Maller JB, Fagerness JA, Reynolds RC, Neale BM, Daly MJ, Seddon JM. Variation in complement factor 3 is associated with risk of age-related macular degeneration. Nat Genet. 2007;39(10):1200-1201.
8. Gold B, Merriam JE, Zernant J, et al AMD Genetics Clinical Study Group. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet. 2006;38(4):458-462.
9. Nozaki M, Raisler BJ, Sakurai E, et al. Drusen complement components C3a and C5a promote choroidal neovascularization. Proc Natl Acad Sci U S A. 2006; 103(7):2328-2333.
10. Jakobsdottir J, Conley YP, Weeks DE, Mah TS, Ferrell RE, Gorin MB. Susceptibility genes for age-related maculopathy on chromosome 10q26.AmJ Hum Genet. 2005;77(3):389-407.
11. Fisher SA, Abecasis GR, Yashar BM, et al. Meta-analysis of genome scans of age-related macular degeneration. Hum Mol Genet. 2005;14(15):2257-2264.
12. Weeks DE, Conley YP, Tsai HJ, et al. Age-related maculopathy: a genomewide scan with continued evidence of susceptibility loci within the 1q31, 10q26, and 17q25 regions. Am J Hum Genet. 2004;75(2):174-189.
13. Iyengar SK, Song D, Klein BE, et al. Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for agerelated macular degeneration. Am J Hum Genet. 2004;74(1):20-39.
14. Seddon JM, Santangelo SL, Book K, Chong S, Cote J. A genomewide scan for age-related macular degeneration provides evidence for linkage to several chromosomal regions. Am J Hum Genet. 2003;73(4):780-790.
15. Majewski J, Schultz DW, Weleber RG, et al. Age-related macular degeneration - a genome scan in extended families. Am J Hum Genet. 2003;73(3):540-550.
16. Yu Y, Reynolds R, Fagerness J, Rosner B, Daly MJ, Seddon JM. Association of variants in the LIPC and ABCA1 genes with intermediate and large drusen and advanced age-related macular degeneration. Invest Ophthalmol Vis Sci. 2011; 52(7):4663-4670.
17. Seddon JM, Reynolds R, Rosner B. Associations of smoking, body mass index, dietary lutein, and the LIPC gene variant rs10468017 with advanced age-related macular degeneration. Mol Vis. 2010;16:2412-2424.
18. Seitsonen SP, Onkamo P, Peng G, et al. Multifactor effects and evidence of potential interaction between complement factor H Y402H and LOC387715 A69S in age-related macular degeneration. PLoS One. 2008;3(12):e3833. doi: 10.1371/journal.pone.0003833.
19. Schaumberg DA, Hankinson SE, Guo Q, Rimm E, Hunter DJ. A prospective study of 2 major age-related macular degeneration susceptibility alleles and interactions with modifiable risk factors. Arch Ophthalmol. 2007;125(1):55-62.
20. Schmidt S, Hauser MA, Scott WK, et al. Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration.AmJHumGenet. 2006;78(5):852-864.
21. Rivera A, Fisher SA, Fritsche LG, et al. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing inde- pendently of complement factor H to disease risk. Hum Mol Genet. 2005;14 (21):3227-3236.
22. Klein ML, Francis PJ, Ferris FL III, Hamon SC, Clemons TE. Risk assessment model for development of advanced age-related macular degeneration. Arch Ophthalmol. 2011;129(12):1543-1550.
23. Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 1992;99(6):933-943.
24. Klein R, Klein BE, Jensen SC, Meuer SM. The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 1997;104(1):7-21.
25. Klein R, Klein BE, Tomany SC, Meuer SM, Huang GH. Ten-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 2002;109(10):1767-1779.
26. Klein R, Klein BE, Knudtson MD, Meuer SM, Swift M, Gangnon RE. Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology. 2007;114(2):253-262.
27. Linton KL, Klein BE, Klein R. The validity of self-reported and surrogatereported cataract and age-related macular degeneration in the Beaver Dam Eye Study. Am J Epidemiol. 1991;134(12):1438-1446.
28. Klein R, Klein BE, Linton KL, De Mets DL. The Beaver Dam Eye Study: visual acuity. Ophthalmology. 1991;98(8):1310-1315.
29. Klein R, Klein BE, Lee KE. Changes in visual acuity in a population: the Beaver Dam Eye Study. Ophthalmology. 1996;103(8):1169-1178.
30. Klein R, Klein BE, Lee KE, Cruickshanks KJ, Chappell RJ. Changes in visual acuity in a population over a 10-year period: the Beaver Dam Eye Study. Ophthalmology. 2001;108(10):1757-1766.
31. Klein R, Klein BE, Lee KE, Cruickshanks KJ, Gangnon RE. Changes in visual acuity in a population over a 15-year period: the Beaver Dam Eye Study. Am J Ophthalmol. 2006;142(4):539-549.
32. Klein R, Klein BE. The Beaver Dam Eye Study: Manual of Operations: Revised. Springfield, VA: National Technical Information Service; 1991. NTIS Publication PB91-149823.
33. Klein R, Klein BE. The Beaver Dam Eye Study II: Manual of Operations. Springfield, VA: National Technical Information Service; 1995. NTIS Publication PB95-273827.
34. Klein R, Klein BE. The Beaver Dam Eye Study III: Manual of Operations. Springfield, VA: National Technical Information Service; 1999. NTIS Publication PB99-137861.
35. Klein BE, Klein R. The Beaver Dam Eye Study V: Manual of Operations. Springfield, VA: National Technical Information Service; 2010. NTIS Publication PB2010-114194.
36. Klein R, Davis MD, Magli YL, Segal P, Klein BE, Hubbard L. The Wisconsin Age-Related Maculopathy Grading System. Springfield, VA: National Technical Information Service; 1991. NTIS Publication PB91-184267.
37. Klein R, Davis MD, Magli YL, Segal P, Klein BE, Hubbard L. The Wisconsin Age-Related Maculopathy Grading System. Ophthalmology. 1991;98(7):1128-1134.
38. Sivakumaran TA, Igo RP Jr, Kidd JM, et al. A 32 kb critical region excluding Y402H in CFH mediates risk for age-related macular degeneration. PLoS One. 2011; 6(10):e25598. doi: 10.1371/journal.pone.0025598.
39. Thompson CL, Klein BE, Klein R, et al. Complement factor H and hemicentin-1 in age-related macular degeneration and renal phenotypes. Hum Mol Genet. 2007; 16(17):2135-2148.
40. Huang L, Li Y, Singleton AB, et al. Genotype-imputation accuracy across worldwide human populations. Am J Hum Genet. 2009;84(2):235-250.
41. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2009.
42. Jackson CH. Multi-state models for panel data: the msm package for R. J Stat Softw. 2011;38(8):1-28.
43. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. Boca Raton, FL: Chapman and Hall/CRC; 1994.
44. Bressler NM, Munoz B, Maguire MG, et al. Five-year incidence and disappearance of drusen and retinal pigment epithelial abnormalities: Waterman study. Arch Ophthalmol. 1995;113(3):301-308.
45. Klaver CC, Assink JJ, van Leeuwen R, et al. Incidence and progression rates of age-related maculopathy: the Rotterdam Study. Invest Ophthalmol Vis Sci. 2001; 42(10):2237-2241.
46. Mitchell P, Wang JJ, Foran S, Smith W. Five-year incidence of age-related maculopathy lesions: the Blue Mountains Eye Study. Ophthalmology. 2002;109(6): 1092-1097.
47. van Leeuwen R, Klaver CC, Vingerling JR, Hofman A, de Jong PT. The risk and natural course of age-related maculopathy: follow-up at 61/2 years in the Rotterdam Study. Arch Ophthalmol. 2003;121(4):519-526.
48. Wang JJ, Foran S, Smith W, Mitchell P. Risk of age-related macular degeneration in eyes with macular drusen or hyperpigmentation: the Blue Mountains Eye Study cohort. Arch Ophthalmol. 2003;121(5):658-663.
49. Ying GS, Maguire MG; Complications of Age-Related Macular Degeneration Prevention Trial Research Group. Development of a risk score for geographic atrophy in Complications of the Age-Related Macular Degeneration Prevention trial. Ophthalmology. 2011;118(2):332-338.
50. Zanke B, Hawken S, Carter R, Chow D. A genetic approach to stratification of risk for age-related macular degeneration. Can J Ophthalmol. 2010;45(1):22-27.
51. Rennie CA, Stinge A, King EA, Sothirachagan S, Osmond C, Lotery AJ. Can genetic risk information for age-related macular degeneration influence motivation to stop smoking? a pilot study. Eye (Lond). 2012;26(1):109-118.
52. Klein R, Klein BE, Moss SE. Relation of smoking to the incidence of age-related maculopathy: the Beaver Dam Eye Study. Am J Epidemiol. 1998;147(2):103-110.
53. Klein R, Klein BE, Myers CE. Risk assessment models for late age-related macular degeneration. Arch Ophthalmol. 2011;129(12):1605-1606.
54. Delcourt C, Delyfer MN, Rougier MB, et al. Associations of complement factor H and smoking with early age-related macular degeneration: the ALIENOR study. Invest Ophthalmol Vis Sci. 2011;52(8):5955-5962.
55. Despriet DD, Klaver CC, Witteman JC, et al. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. JAMA. 2006;296(3):301-309.
56. Ferris FL, Davis MD, Clemons TE, et al Age-Related Eye Disease Study (AREDS) Research Group. A simplified severity scale for age-related macular degeneration: AREDS report No. 18. Arch Ophthalmol. 2005;123(11):1570-1574.
57. Gangnon RE, Lee KE, Klein BEK, Iyengar SK, Sivakumaran TA, Klein R. Effect of the Y402H variant in the complement factor H gene on the incidence and progression of age-related macular degeneration: results from multistate models applied to the Beaver Dam Eye Study. Arch Ophthalmol. 2012;130(9):1169-1176.
58. Hughes AE, Orr N, Patterson C, et al. Neovascular age-related macular degeneration risk based on CFH, LOC387715/HTRA1, and smoking. PLoS Med. 2007; 4(12):e355. doi: 10.1371/journal.pmed.0040355.
59. Klein R, Cruickshanks KJ, Nash SD, et al. The prevalence of age-related macular degeneration and associated risk factors. Arch Ophthalmol. 2010;128(6):750-758.
60. Magnusson KP, Duan S, Sigurdsson H, et al. CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD. PLoS Med. 2006;3(1):e5. doi: 10.1371/journal.pmed.0030005.
61. Ryu E, Fridley BL, Tosakulwong N, Bailey KR, Edwards AO. Genome-wide association analyses of genetic, phenotypic, and environmental risks in the Age-Related Eye Disease Study. Mol Vis. 2010;16:2811-2821.
62. Thompson CL, Jun G, Klein BE, et al. Genetics of pigment changes and geographic atrophy. Invest Ophthalmol Vis Sci. 2007;48(7):3005-3013.
63. Xing C, Sivakumaran TA, Wang JJ, et al. Complement factor H polymorphisms, renal phenotypes and age-related macular degeneration: the Blue Mountains Eye Study. Genes Immun. 2008;9(3):231-239.
64. Munch IC, Ek J, Kessel L, et al. Small, hard macular drusen and peripheral drusen: associations with AMD genotypes in the Inter99 Eye Study. Invest Ophthalmol Vis Sci. 2010;51(5):2317-2321.
65. Klein R, Knudtson MD, Klein BE, et al. Inflammation, complement factor H, and age-related macular degeneration: the Multi-ethnic Study of Atherosclerosis. Ophthalmology. 2008;115(10):1742-1749.
66. Tedeschi-Blok N, Buckley J, Varma R, Triche TJ, Hinton DR. Population-based study of early age-related macular degeneration: role of the complement factor H Y402H polymorphism in bilateral but not unilateral disease. Ophthalmology. 2007;114(1):99-103.
67. Weismann D, Hartvigsen K, Lauer N, et al. Complement factor H binds malondialdehyde epitopes and protects from oxidative stress. Nature. 2011;478(7367): 76-81.
68. Fritsche LG, Loenhardt T, Janssen A, et al. Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA. Nat Genet. 2008; 40(7):892-896.
69. Kortvely E, Hauck SM, Duetsch G, et al. ARMS2 is a constituent of the extracellular matrix providing a link between familial and sporadic age-related macular degenerations. Invest Ophthalmol Vis Sci. 2010;51(1):79-88.
70. Kanda A, Chen W, Othman M, et al. A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration. Proc Natl Acad Sci U S A. 2007;104(41):16227-16232.
71. Smailhodzic D, Klaver CC, Klevering BJ, et al. Risk alleles in CFH and ARMS2 are independently associated with systemic complement activation in age-related macular degeneration. Ophthalmology. 2012;119(2):339-346.